Biotech
$XAIR Symmetrical Triangle BreakBeyond Air has continued a strong uptrend since June. Recently its bin tapering and has shown a symmetrical triangle formation. A Brake out to the upside is likely to continue the uptrend. Watch for a move past the top of the triangle at 11.88 level for conformation and more possible upside. No resistance till 12.50 a high not seen since March 4, 2020
$PFE - Key Levels and Analysis - REQUEST - I hold no position$PFE - Key Levels and Analysis
—————
@Smartdaytrading, I think that PFE is overdue for a trip back toward the 180EMA(Purple)… Right now it is sitting right under the 35 EMA (Red) and this week if it closes under the gray line right under the red then I’d say watch for 41.64… that would be a good place to add if you’re long…
The 35EMA has held as support for a large part of this year, but it tends to become resistance once it crosses down (and actually closes with the entire candle under the 35EMA)… and it’s been a little too long since it’s corrected back to the 180…
Anything can happen... but I'd say keep a close eye on 41-42 area
——————
I am not your financial advisor, but I will happily answer questions and analyze to the best of my ability but ultimately the risk is on you.
Red = Resistance
Green = Support
Blue = trendlines
Have fun, y’all!!
FEMY Femasys Bull PennantOn 7/13/2021 Jonestrading brokerage Initiated Coverage with a Buy rating and a $8.45 Price Target
On 7/13/2021 Chardan Capital brokerage Initiated Coverage with a Buy rating and a $25.00 Price Target
How do you explain such a big difference in valuation?
Where do you see this Bull Pennant heading?
LABD break outI have been tackling LABD/LABU day in and day out. I have somehow made some profit week by week. I am trying to figure out which was the better trade as I think it has come to the tipping point. I believe LABD is the winner. I see bearish sentiment in the short term market and I see an inverse head and shoulders or a cup and handle formation. On LABU I confirmed it because whichever way I look at it it is the opposite, head and shoudler pattern, inverse cup and handle.
VERTEX CAN GO UP Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. Excellent bullish divergence on the monthly. Great time for a long trade on this asset that could attempt a retarget in the $ 240 zone.
AXNX: Calls on IncontinencePromising biotech setup here, had a nice break of 70 recently and may be looking to go higher. Potentially risky if XBI rolls over but strong momentum here nonetheless. Good luck traders!
MIRO Miromatrix Medical Price TargetMiromatrix Medical Inc. engages in the development of biological human organs to solve the chronic shortage of transplantable organs.
114,000 people in the U.S. are waiting for a life-saving organ transplant, and more than half will die due to a lack of available organs.
Miromatrix Medical trial is expected to begin in the second half of 2022 and will assess the function of a bioengineered liver in humans via an external application.
if it succeeds, the opportunity to buy the stock at these prices will be history.
The Market Cap of MIRO is just 214.74Mil
On 7/19/2021 Craig Hallum brokerage Initiated Coverage with a Buy rating and a $22.00 price target
AUPH BREAKOUTBULLISH WEDGE
Been brewing since FDA approval of Voclosporin. Lots of reasons to speculate a buyout or possible merger with recent voluntary delisting from the TSX and remaining on NYSE. Excellent setup to be a cash cow. Target Price of $35 be EOY playing Oct Calls. PFE and MRNA are LOADED with cash and you know they're sniffing out opportunities and would love to hear your thoughts and positions on this!
$ESPR Short squeeze - 1 D Candle I think ESPR could start to get interested in this level .
- After a long decline from the peak ($ 40) this year, on 27/1/2021, we are now witnessing a consolidation in the price level.
- I do not look at fundamental information, only technical data .
Indicators :
* EMA21 is the purple line
* EMA9 is the green line
* Consolidation at Slow Stochastic
* RSI begins to change direction
- 26.23M short float (low float)
- Setup: Falling Wedge
- Short floating percentage 32.48%
- Above the consolidation at 15$ squeeze can happen
* It can be very aggressive .. think of all the Short's sellers who will have to cover positions after they see a price level break after consolidation ...
* No financial advice just my personal opinion, make your own DD!
ABCL - 20-30% UPSIDE - LONGAll,
ABCL is for massively oversold on weekly down so regardless how you feel about the stock (even though price target analysts are WAY higher) this is due for a rip. Not to mention this is a perfect situation for institutions to enter into ABCL at a pretty big discount from fair value etc.
I am temporarily waiting next few days watch it extremely closely then entering unless it breaks through the bottom.
Feel free to do your DD on ABCL they actually have really good positive pipelines just being held down.